Legal Notice Regarding Trademark/Brand Confusion: SunnyD STAT vs SUNDION (Vitamin D Products)
Legal Notice Regarding Trademark/Brand Confusion · Islamabad · Jang,
Notice advertisement published in Jang on Tuesday, 28 July 2026, listed under Islamabad.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
Scotmann Pharmaceuticals (Islamabad) and Nutrifactor Laboratories (Pvt.) Ltd. have published a legal notice regarding potential trademark/packaging confusion between two vitamin products marketed under the brand names "SunnyD STAT" (softgel) and "SUNDION" (Vitamin D3). The notice refers to ongoing intellectual property proceedings before the IP Tribunal and cites a stay/order related to use or marketing of the contested get-up/mark.
Consumers, distributors, and retailers are advised to note the potential confusion and act cautiously when sourcing or selling these products. For resolution of the dispute, the notice directs enquiries and legal correspondence to the instructing law firm.
| Product | Formulation / Noted Claim | Manufacturer / Party Named |
|---|---|---|
| SunnyD STAT | Softgel capsule / marketed as immune booster (brand get-up referenced) | Scotmann Pharmaceuticals (Islamabad) referenced |
| SUNDION | Vitamin D3 (Cholecalciferol) — 200,000 IU (labelled) | Nutrifactor Laboratories (Pvt.) Ltd. referenced |
Legal representative: Talib Ali Shah, Attorney at Law, Ali & Associates (firm contact details and office addresses are provided in the original notice for legal correspondence).
Purpose: Public/legal advisory about trademark/packaging dispute and IP Tribunal proceedings; recipients (distributors, retailers, and the public) are warned about possible infringement/confusion and asked to obtain legal clarity before marketing or distributing the contested products.
Published in Jang on Tuesday, 28 July 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.